Developing risk stratification strategies and biomarkers for recurrent hepatocellular carcinoma
Abstract Hepatocellular carcinoma (HCC) remains a leading cause of cancer‐related mortality, with high rates of post‐resection recurrence posing significant clinical challenges. Early recurrence is largely driven by aggressive tumor biology, while late recurrence reflects de novo carcinogenesis in a...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2025-08-01
|
| Col·lecció: | Clinical and Translational Medicine |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1002/ctm2.70410 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|